Roth Capital lowered the firm’s price target on Hyster-Yale (HY) to $40 from $50 and keeps a Buy rating on the shares after its Q3 results. Conditions stay challenging given the impact of market uncertainties and tariffs on both customer decision-making and underlying product profitability, as forward visibility looks much more limited currently, the analyst tells investors in a research note.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HY: